XML 36 R25.htm IDEA: XBRL DOCUMENT v3.20.2
COMMITMENTS, CONTINGENCIES, AND CONCENTRATIONS (Details)
3 Months Ended 9 Months Ended
Nov. 03, 2020
Lawsuit
Jan. 03, 2020
USD ($)
shares
Sep. 30, 2020
USD ($)
KeyEmployee
Sep. 30, 2019
USD ($)
Sep. 30, 2020
USD ($)
Applicants
KeyEmployee
Sep. 30, 2019
USD ($)
Dec. 31, 2019
USD ($)
Sep. 03, 2019
USD ($)
Concentrations [Abstract]                
Sales     $ 10,272,478 $ 9,720,939 $ 22,243,234 $ 27,613,291    
Accounts Receivable     $ 3,522,498   $ 3,522,498   $ 3,661,325  
Employment Contracts [Abstract]                
Number of key employees with whom Company has employment contracts | KeyEmployee     2   2      
Aggregate annual salaries of employment contracts         $ 765,000      
Contract one, expiration date         Dec. 31, 2020      
Contract two, expiration date         Dec. 31, 2022      
Future minimum salary commitments [Abstract]                
2020     $ 191,250   $ 191,250      
2021     765,000   765,000      
2022     400,000   $ 400,000      
Pension Plan [Abstract]                
Percentage of employer's matching contribution         40.00%      
Expenses related to matching contribution         $ 71,154 74,600    
Components of Lease Expense [Abstract]                
Operating lease expense     405,989 425,757 1,258,797 1,108,016    
Finance lease cost [Abstract]                
Amortization of right-of-use assets     15,571 11,686 42,657 11,686    
Interest on lease liabilities     5,395 4,033 14,762 4,033    
Total finance lease expense     20,966 15,719 57,419 15,719    
Cash paid for amounts included in the measurement of lease liabilities [Abstract]                
Operating cash flows for operating leases     340,205 158,050 797,482 474,150    
Operating cash flows for finance leases     5,395 4,033 14,762 4,033    
Financing cash flows for finance leases     13,587 9,851 37,166 9,851    
Right-of-use assets obtained in exchange for lease obligations [Abstract]                
Operating leases     0 0 0 6,697,896    
Finance leases     5,486 0 73,600 222,036    
Finance Leases [Abstract]                
Finance lease right of use asset     315,153 233,722 315,153 233,722    
Accumulated depreciation     (66,261) (11,686) (66,261) (11,686)    
Finance lease right of use asset, net     $ 248,892 $ 222,036 $ 248,892 $ 222,036 210,350  
Weighted Average Remaining Lease Term [Abstract]                
Operating leases     9 years 1 month 6 days 9 years 10 months 24 days 9 years 1 month 6 days 9 years 10 months 24 days    
Finance leases     4 years 4 years 9 months 18 days 4 years 4 years 9 months 18 days    
Weighted Average Discount Rate [Abstract]                
Operating leases     8.60% 8.51% 8.60% 8.51%    
Finance leases     8.18% 7.00% 8.18% 7.00%    
Maturities of Operating Lease Liabilities [Abstract]                
2019 and 2020     $ 342,462 $ 158,050 $ 342,462 $ 158,050    
2021     1,209,787 813,443 1,209,787 813,443    
2022     1,057,757 998,071 1,057,757 998,071    
2023     1,026,272 1,026,044 1,026,272 1,026,044    
2024     1,018,875 1,011,085 1,018,875 1,011,085    
Thereafter     5,773,888 6,792,762 5,773,888 6,792,762    
Total lease payments     10,429,041 10,799,455 10,429,041 10,799,455    
Less: imputed interest     3,269,991 3,837,507 3,269,991 3,837,507    
Total     7,159,050 6,961,948 7,159,050 6,961,948    
Maturities of Finance Lease Liabilities [Abstract]                
2019 and 2020     19,226 13,884 19,226 13,884    
2021     76,904 55,536 76,904 55,536    
2022     76,904 55,536 76,904 55,536    
2023     76,904 55,536 76,904 55,536    
2024     49,136 55,536 49,136 55,536    
Thereafter     5,750 27,767 5,750 27,767    
Total lease payments     304,824 263,795 304,824 263,795    
Less: imputed interest     46,712 39,924 46,712 39,924    
Total finance lease liability     258,112 223,871 $ 258,112 223,871    
Employee Litigation [Abstract]                
Exercise price of stock options   $ 943,126            
Vested shares exercisable (in shares) | shares   266,666            
Term to exercise stock options         30 days      
Number of motions for appointment as lead plaintiff | Applicants         2      
Vendor 1 [Member]                
Concentrations [Abstract]                
Purchases     501,562 0 $ 1,600,916 0    
Accounts Payable     178,395   178,395   0  
Customer Concentration Risk [Member] | Customer 1 [Member]                
Concentrations [Abstract]                
Accounts Receivable     1,622,866   1,622,866   941,962  
Customer Concentration Risk [Member] | Customer 2 [Member]                
Concentrations [Abstract]                
Accounts Receivable     0   0   0  
Customer Concentration Risk [Member] | Customer 3 [Member]                
Concentrations [Abstract]                
Accounts Receivable     17,510   $ 17,510   $ 0  
Subsequent Event [Member]                
Employee Litigation [Abstract]                
Number of class action lawsuits | Lawsuit 4              
Maximum [Member]                
Pension Plan [Abstract]                
Employee contribution subject to employer matching contribution         5.00%      
Employer matching contribution         2.00%      
Senior Secured Term Loan Credit Facility [Member]                
Leases [Abstract]                
Debt instrument, face amount               $ 20,000,000
Sales [Member] | Customer Concentration Risk [Member] | Customer 1 [Member]                
Concentrations [Abstract]                
Sales     $ 4,226,040 $ 3,966,142 $ 6,523,416 $ 10,012,644    
Concentration risk, percentage     50.30% 46.60% 36.40% 42.80%    
Sales [Member] | Customer Concentration Risk [Member] | Customer 2 [Member]                
Concentrations [Abstract]                
Sales     $ 1,071,513 $ 0 $ 0 $ 0    
Concentration risk, percentage     12.70% 0.00% 0.00% 0.00%    
Sales [Member] | Customer Concentration Risk [Member] | Customer 3 [Member]                
Concentrations [Abstract]                
Sales     $ 963,671 $ 0 $ 0 $ 0    
Concentration risk, percentage     11.50% 0.00% 0.00% 0.00%    
Purchases [Member] | Vendor 1 [Member]                
Concentrations [Abstract]                
Concentration risk, percentage     15.40% 0.00% 12.30% 0.00%